Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSНаши коллеги (IQVIA Russia & CIS) приняли участие в работе международной студенческой онлайн школы «Особенности регистрационной политики и разработки лекарственных средств в РФ, странах ЕАЭС и ЕС», которая стартовала в Сеченовском Университете в октябре 2020 г. Это масштабный образовательный проект для студентов старших курсов зарубежных медицинских и фармацевтических вузов.
В течение 4 академических часов Николай Демидов (Генеральный директор IQVIA, России и СНГ) и Алексей Савин (Старший директор, Consulting East Europe) рассказали об основных тенденциях и факторах развития фармацевтического рынка в России, странах ЕАЭС и ЕС, трендах и факторах развития фармацевтического рынка России, странах ЕАЭС и ЕС.
На лекциях наших коллег присутствовали около 1400 студентов из разных стран (Беларусь, Болгария, Великобритания, Венгрия, Германия, Греция, Индия, Испания, Италия, Казахстан, Китай, Россия, Сингапур, Словения, США, Франция, Хорватия, Япония). Студенты из Китая составили более половины слушателей.
Такой успех и интерес можно объяснить тем, что студенты зарубежных вузов, получающие фармацевтическое образование, в качестве работы рассматривают фармкомпании своих стран, которые в том числе работают в России и СНГ. Знание рынка станет для них конкурентным преимуществом при трудоустройстве. Это хорошее начало, поздравляем наших коллег и желаем дальнейшего развития компетенций в этой области.